Erratum to: Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0)

M. Shivakumar, P. Jayashree, Muhammad Najih, Leslie Edward Simon Lewis, Y. Ramesh Bhat, Asha Kamath, Shashikala

Research output: Contribution to journalComment/debate

Abstract

In Table II, P value in first row (against ‘continuing apnea’ at 1–3 d of therapy) should be 0.05 in place of 0.03; and in second row (against ‘continuing apnea’ at 4–7 d of therapy), P value should be 0.03 in place of 0.05. In Fig. 1, the number in the frame “Neonates completed treatment and follow-up” in the Caffeine group should be read as 77 in place of 79; and in the Aminophylline group, it should be 79 in place of 77.

Original languageEnglish
Number of pages1
JournalIndian Pediatrics
Volume54
Issue number10
DOIs
Publication statusPublished - 01-10-2017

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Erratum to: Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0)'. Together they form a unique fingerprint.

  • Cite this